Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$16.6

Avg closing price
Price range

9 Steven Cohen 4D Molecular Therapeutics Trades

The first 4D Molecular Therapeutics trade was made in Q3 2022. Since then Steven Cohen bought shares four more times and sold shares on four occasions. The investor sold all their shares in Q4 2024 and doesn't own any shares in 4D Molecular Therapeutics anymore.

Avg closing price
Price range
Sold -15.3 Thousand shares Q4 2024
Avg closing price $7.79
Price range $5.30 - $10.41
New holding (+15.3 Thousand shares) Q3 2024
Avg closing price $16.64
Price range $10.81 - $27.22
Sold -416 Thousand shares Q1 2024
Avg closing price $25.51
Price range $17.03 - $35.87
Sold 8.2% shares (-37.4 Thousand shares) Q4 2023
Avg closing price $13.16
Price range $9.76 - $21.25
Increased shares by 22.2% (+82.5 Thousand shares) Q3 2023
Avg closing price $16.73
Price range $12.64 - $19.76
Increased shares by 77.5% (+162 Thousand shares) Q2 2023
Avg closing price $18.41
Price range $15.16 - $23.26
Increased shares by 50.0% (+69.6 Thousand shares) Q1 2023
Avg closing price $19.45
Price range $15.45 - $23.19
Sold 53.4% shares (-160 Thousand shares) Q4 2022
Avg closing price $15.45
Price range $6.85 - $25.46
New holding (+299 Thousand shares) Q3 2022
Avg closing price $9.06
Price range $6.96 - $11.48

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!